Friday, March 21, 2025

Eyenovia, Betaliq Pursue Merger

The companies seek to combine their drug delivery technologies in a potential $92 million transaction.

Tuesday, March 18, 2025

Iantrek Reports Positive Results from Cyclodialysis Study

The bioreinforced cyclodialysis procedure using the CycloPen system reduced IOP and medication use over 2 years.

Tuesday, March 11, 2025

Topcon, RadiusXR, and Glaukos Launch Wearable Vision Test Platform

The Inspire device integrates diagnostic technology with patient education and data analysis.

Friday, March 7, 2025

Optos Expands Retinal Imaging Database

The enhanced dataset will help clinicians detect and manage eye diseases at an earlier stage.

Tuesday, March 4, 2025

Altris AI Launches Advanced Optic Disc Analysis for Glaucoma

The AI-powered Advanced Optic Disc Analysis module evaluates optic disc parameters using optical coherence tomography, providing personalized assessments by accounting for individual disc sizes and angle of rim absence.

Tuesday, March 4, 2025

Haag-Streit Launches the METIS 900 Ophthalmic Microscope

The new ophthalmic microscope system brings Haag-Streit’s optics into the operating room, providing sharp clarity and precision during ophthalmic surgeries.

Friday, February 28, 2025

Prevent Blindness Declares March Workplace Eye Wellness Month

The goal of the annual observance is to provide employers and employees with important information to help keep eyes safe and healthy at work.

Friday, February 21, 2025

Event Dedicated to Integrative Eye Health Scheduled

The Eye Health Summit, a new global patient-centered event dedicated to integrative eye health, will take place May 1-7 as a free hybrid event. 

Wednesday, February 19, 2025

Voyager DSLT Device Now Available in the US

Alcon’s automated laser enables treatment without a gonio lens or manual aiming.

Tuesday, February 18, 2025

VIA360 Surgical System Receives 510(k) Clearance

New World Medical's device can be used to deliver viscoelas­tic fluid and perform trabeculotomy.

Saturday, February 15, 2025

Optos Launches MonacoPro With Expanded Capabilities

The next-generation system integrates ultrawidefield imaging with improved diagnostic support.

Friday, February 14, 2025

Glenmark Launches Latanoprost Ophthalmic Solution 0.005%

Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL) is a bioequivalent and therapeutically equivalent to the reference listed drug, Xalatan Ophthalmic Solution, 0.005% of Upjohn US 2 LLC, the company said in a press release.

Thursday, February 13, 2025

Virtual Eye Platform Expands Diagnostic Capabilities

The VR-based system now includes visual acuity testing alongside other eye exams.

Wednesday, February 5, 2025

QLS-111 Demonstrates Efficacy in Trials

Qlaris Bio reports positive phase 2 results for its investigational drug treatment QLS-111 in glaucoma and OHT patients.

Wednesday, February 5, 2025

Iantrek Appoints New CEO

Adam Szaronos takes over top leadership role from company founder Dr. Sean Ianchulev, who will remain involved as board chair and CMO.

Monday, February 3, 2025

BVI Medical Launches Educational Platform for Ophthalmic Surgeons

EyeXchange Solutions connects experienced and emerging surgeons across cataract, glaucoma, and retina specialties to share insights, refine techniques, and address complex cases. 

Thursday, January 23, 2025

AMA Prior Authorization Statement

The American Medical Association comments on a recent statement by US insurer UnitedHealth that it will work toward easing prior authorization rules.

Wednesday, January 22, 2025

Heidelberg Symposium to Showcase Glaucoma Innovations

The event will highlight the growing role of artificial intelligence in glaucoma diagnosis and management.

Tuesday, January 14, 2025

Bausch + Lomb, Glaucoma Research Foundation Launch Second Annual ‘Faces of Glaucoma’ Campaign and Fundraising Challenge

Throughout January, Bausch + Lomb and Glaucoma Research Foundation will spotlight educational resources and share stories of individuals and families living with glaucoma to raise awareness of the disease.

Monday, January 13, 2025

Bausch + Lomb Acquires Whitecap Biosciences

With innovative therapies addressing glaucoma and geographic atrophy currently in development, the acquisition of Whitecap Bioscience's strengthens B + L’s expanding clinical-stage pipeline. 

Tuesday, January 7, 2025

Canyon Labs Acquires iuvo BioScience’s Lab Division

The deal allows each company to focus on strengths.